Article
Drug repositioning in response to COVID-19 and other challenging diseases
2024-01-31
Abstract excerpt
There are over 90 clinical trials including drug repositioning that have been initiated to get COVID-19 treatment/management. Antibiotic resistance, drug tolerance, mutation and adverse drug effects possess a great deal of setback during therapy especially with emerging infectious diseases and this necessitates the need for research into getting new drugs or repositioning the existing ones to meet up with the trea...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- f79d70d1-ac86-50b3-be0a-af1c7e8b2283
- DOI
- 10.22541/au.170670501.14884284/v1
